1. R-Pharm Drugs Technology is one of the leading Russian
pharmaceutical companies in R&D and Manufacturing
of generic and original drug formulations.
Delivering hope is
not our profession.
It’s our passion.
2. Our Mission
At R-Pharm DrugsTech we
strive to develop the highest
quality affordable Generic
Drugs in Russia and Overseas.
• Cost-effective production of high-quality Generic Drugs
• Development of effective Brand Drugs with increased safety for
patients
• High-Profile International Scientific Collaborations in Drug Discovery
• New commercial opportunities for international expansion
3. 2001
Alexey Repik inaugurates the novel idea of R-Pharm as a medicinal
products distributer in Russian Public Healthcare System.
2003-2007
R-Pharm successfully expands distribution over the entire territory
of RF becoming the preferred partner for the Big Pharma in Russia.
2012
Leading Distributor of Russia in Hospital/Specialty Care market.
Acquisition of Drugs Technology LLC to solidify R-Pharm’s market
position in the Generics Market.
2010-2013
R&D Partnerships and BD Units established in India, Japan,
Turkey/MENA. API, F&F site in Turkey being designed.
Commercial operations launched in UAE.
2011-2014
R&D and Business Development operations launched in the USA.
R-Pharm US LLC established.
2013-2014
Acquired a state-of-the art manufacturing site from Pfizer in Germany.
R-Pharm US R&D and Business Development operations launched.
2015-2016
R-Pharm becomes the first fully integrated
Russian multinational pharmaceutical
company in the world.
About R-Pharm DrugsTech
Drugs Technology LLC (DrugsTech), part of Global R-Pharm Group of Companies
is one of the leading innovative pharmaceutical corporations of Russia having more
than 100 Generic Drug formulations and 13 Original dosage forms covering more
than 12 therapeutic areas.
Our Brand name Portfolio include nano-particulate and liposomal drug delivery
systems at Clinical Trials created in conjunction with leading research universities
in Russia and abroad, involving key scientific figures and organizations worldwide.
Our Story
2007
Established in Industrial Town
of Khimki, Moscow Area, Russia.
2010
The first generics are introduced
to the market.
2012
Became part of R-Pharm Group, the
leading distributor of medicinal products
in Russian Public Healthcare System,
providing full cycle drug development
from API manufacturing to marketing
and sales of finished dosage forms.
Drugs Technology R-Pharm
1
4. Diverse Portfolio
in more than 12
therapeutic areas
Market Leadership
in Key Specialty
Care Areas
High in-class
Quality Standards
in R&D and
Manufacturing
Our Generics Business
• Scale API and F&F Manufacturing facilities according to GMP
Standards
• Portfolio More than 100 Generics in more than 12 therapeutic
categories
• Leadership Domestic Market share 37%
• Dedicated Oncology, Viral Infections (HIV, Hepatitis), Psychiatry
Development
Areas
• Competences Deeply experienced in full-cycle R&D and Manufacturing
from API Standardization to Scale Up & Technology
Transfer
• Commercialization As part of Global R-Pharm Group Drugs Technology has
power an unmatched commercialization power in Russia & CIS
with experienced commercial groups in Turkey/MENA,
Germany, USA in total of 9 countries.
• State of the art
manufacturing Solid forms, Sterile F&F, Biosimilar, small molecule API
sites in Russia production.
and Overseas
• Regulatory Deep experience in Regulatory with fast track
opportunities in Russia & CIS
2
6. R&D and Manufacturing Capabilities
A team of 150 talented and highly-skilled scientists in Khimki
R&D and Manufacturing Site ensure the highest Quality level
of our generics based on GMP Standards
• 5 R&D Laboratories
• API Manufacturing
• Solid Forms Manufacturing
• Sterile Finished Forms
• Nano-sized formulations
4
7. Since 2011 DrugsTech has been
developing its own innovative line of Brand
Name Drugs.
The company is developing original drugs
and Drug Delivery Systems in the
following areas:
Brand Name Drug
Portfolio
• Biomedical polymeric nanotechnology platform for
targeted drug delivery across the Blood-Brain Barrier;
• Nano-formulatins of antibiotics;
• Innovative Brand Liposomal Drug Formulations;
• Microspheres for Embolization and Chemoembolization;
• MODIFIED RELEASE PARTICLES (Depot Forms);
• Modified PEPTIDES for Diabetes treatment, Pain-killers,
Bacterial infections.
5
8. Innovative Drug Delivery Systems
LIPOSOMAL PORTFOLIO:
• Liposomal Docetaxel
• Liposomal Irinotecan
• Liposomal Oxaliplatin
• Liposomal Sarcolysin
• Liposomal Rifabutin
POLIMERIC NANOPARTICLES:
• Doxorubicin in PLGA nanoparticles
• Carbamazepine in nanoparticles
• Loperamide in nanoparticles
6
10. Building Global Partnerships
Being the Generics Arm of R-Pharm in Russia Drugs
Technology is an ideal partner for your generics and
brand drug business partnerships and join-ventures
in Russia and overseas. Our core competences
in R&D and Manufacturing coupled by R-Pharm’s
renowned commercialization and investment prowess
allow us to drive deals from early stage drug
discovery to market access, distribution and full-scale
marketing support with any perspective scientific,
commercial or industrial partner. We are open to any
mutually beneficial exchange of ideas and thoughts
on any possible cooperation with you.
Our Values
Innovation Integrity Reliability Service Teamwork
8
11. Disclaimer
This document may include claims that may appear as “forward-looking
statements”. Such statements inherently involve risks and uncertainties, ac-
tual future results may differ substantially from those expressed or implied
by such forward-looking statements. Factors causing or contributing to such
differences include, but are not limited to: any legal or regulatory challenges
to the settlement; strategies by competitors or other third parties to delay or
prevent product introductions; risks inherent in legal and regulatory processes;
and the other risks detailed in company’s periodic filings. The company under-
takes no obligation to update these statements for revisions or changes after
the date of this release.
12. DRUGS TECHNOLOGY LLC
R-Pharm Group of Companies
141400, Moscow Urban Area
Industrial Town of Khimki
Rabochaya Street 2A, Bldg.1
www.drugsformulation.ru
+7 495 225 6200
